4.7 Article

Endoscopic management of colonic perforations: clips versus suturing closure

期刊

GASTROINTESTINAL ENDOSCOPY
卷 84, 期 3, 页码 487-493

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.gie.2015.08.074

关键词

-

向作者/读者索取更多资源

Background and Aims: Perforation during colonoscopy remains the most worrisome adverse event and usually requires urgent surgical rescue. The aim of this study was to evaluate the feasibility and effectiveness of endoscopic closure of full-thickness colonic perforations. Methods: We performed a retrospective analysis of all consecutive patients with endoscopically closed colonic perforations over the past 6 years (2009-2014). Colonic perforations were closed by using endoscopic clips or an endoscopic suturing device. Most patients were admitted for treatment with intravenous antibiotics and kept on bowel rest. If their clinical condition deteriorated, urgent surgery was performed. If patients remained stable, oral feeding was resumed, and patients were discharged with subsequent clinical and endoscopic follow-up. Results: Twenty-one patients had iatrogenic colonic perforations closed with an endoscopic suturing device or endoscopic clips during the study period. Primary closure of a colonic perforation was performed with endoscopic clips in 5 patients and sutured with an endoscopic suturing device in 16 patients. All 5 patients after clip closure had worsening of abdominal pain and required laparoscopy (4 patients) or rescue colonoscopy with endoscopic suturing closure (1 patient). Two patients had abdominal pain after endoscopic suturing closure, but diagnostic laparoscopy confirmed complete and adequate endoscopic closure of the perforations. The other 15 patients did not require any rescue surgery or laparoscopy after endoscopic suturing. The main limitation of our study is its retrospective, single-center design and relatively small number of patients. Conclusion: Endoscopic suturing closure of colonic perforations is technically feasible, eliminates the need for rescue surgery, and appears more effective than closure with hemostatic endoscopic clips.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

Katherin Zambrano-Vera, Armando Sardi, Felipe Lopez-Ramirez, Michelle Sittig, Carlos Munoz-Zuluaga, Carol Nieroda, Vadim Gushchin, Teresa Diaz-Montes

Summary: This study found that among EOC patients aged 65 years or older, those treated with CRS/HIPEC had comparable outcomes to patients under 65 years old, while there were slight differences in survival for those treated with NACT + CRS/HIPEC and salvage CRS/HIPEC. Age and feasibility of complete cytoreduction should be considered when selecting treatment methods for elderly patients.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience

Andrei Nikiforchin, Vadim Gushchin, Mary Caitlin King, Ekaterina Baron, Carol Nieroda, Michelle Sittig, Armando Sardi

Summary: CRS/HIPEC in a non-academic setting is a safe option for treating PSM with favorable surgical and oncological outcomes, despite the presence of major complications and low mortality rates. Incomplete cytoreduction and major complication rates decrease over time, while mortality remains low and constant.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C

Ekaterina Baron, Carolina Velez-Mejia, Michelle Sittig, John Spiliotis, Andrei Nikiforchin, Felipe Lopez-Ramirez, Vadim Gushchin, Armando Sardi

Summary: Genital necrosis (GN) is a rare and serious complication after CRS/HIPEC surgery, with a median onset time of 64 days and symptoms including severe pain, edema, skin ulceration, etc. Treatment strategy involves initial conservative management followed by surgical debridement after complete lesion demarcation.
Editorial Material Oncology

ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients With Intrapleural Dissemination of Peritoneal Surface Malignancies

Andrei Nikiforchin, Vadim Gushchin, Mary Caitlin King, Ekaterina Baron, Felipe Lopez-Ramirez, Armando Sardi

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases

Andrei Nikiforchin, Vadim Gushchin, Michelle Sittig, Ekaterina Baron, Felipe Lopez-Ramirez, Carol Nieroda, Armando Sardi

Summary: This study retrospectively evaluated the impact of diaphragmatic resection (DR) during CRS/HIPEC on patient outcomes. Results showed that DR did not increase morbidity and mortality, but was associated with worse survival in patients with appendiceal and colorectal tumors, particularly after adjusting for tumor burden.

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix

Felipe Lopez-Ramirez, Vadim Gushchin, Michelle Sittig, Mary Caitlin King, Ekaterina Baron, Andrei Nikiforchin, Carol Nieroda, Armando Sardi

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix

Felipe Lopez-Ramirez, Vadim Gushchin, Michelle Sittig, Mary Caitlin King, Ekaterina Baron, Andrei Nikiforchin, Carol Nieroda, Armando Sardi

Summary: This study analyzed the recurrence of mucinous carcinomatosis peritonei (MCP) after the first cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for appendiceal tumors (AT) and compared the outcomes between patients who underwent iterative CRS/HIPEC and those who did not. The study found that selected low- and high-grade appendiceal cancer patients with MCP recurrence who were able to undergo iterative CRS/HIPEC procedures showed favorable outcomes. However, there was no evidence supporting a survival benefit with iterative CRS/HIPEC in recurrent MCP with signet ring cell morphology.

ANNALS OF SURGICAL ONCOLOGY (2022)

Letter Oncology

Reply to: Letter to editor - Rare, but severe: Delayed Genitoscrotal necrosis after HIPEC with Mitomycin-C

Ekaterina Baron, Vadim Gushchin, John Spiliotis, Mary Caitlin King, Armando Sardi

Article Oncology

Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC

Ekaterina Baron, Armando Sardi, Mary Caitlin King, Andrei Nikiforchin, Felipe Lopez-Ramirez, Carol Nieroda, Vadim Gushchin, Panayotis Ledakis

Summary: This study evaluated the efficacy of systemic chemotherapy in improving the overall survival of high-grade mucinous appendiceal cancer patients with unresectable peritoneal metastases, and found that systemic chemotherapy was associated with improved survival.

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Author Reflections: CRS/HIPEC Cannot be Done-Now what? Systemic Chemotherapy in Mucinous Appendiceal Cancer

Ekaterina Baron, Mary Caitlin King, Vadim Gushchin, Armando Sardi, Panayotis Ledakis

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

Ekaterina Baron, Armando Sardi, Mary Caitlin King, Andrei Nikiforchin, Felipe Lopez-Ramirez, Carol Nieroda, Vadim Gushchin, Panayotis Ledakis

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Ekaterina Baron, Armando Sardi, Mary Caitlin King, Andrei Nikiforchin, Felipe Lopez -Ramirez, Carol Nieroda, Vadim Gushchin, Panayotis Ledakis

Summary: This study evaluated the association between adjuvant chemotherapy (ACT) and survival in stage IVA/B high-grade mucinous appendiceal cancer patients treated with CRS/HIPEC. The results showed that ACT was not associated with better overall survival (OS) compared to no chemotherapy (NoCT) in this cohort. The findings may be attributed to differences in tumor biology or the small sample size.
Article Oncology

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma

Felipe Lopez-Ramirez, Armando Sardi, Kimberley Studeman, Mary Caitlin King, Luis Felipe Falla-Zuniga, Andrei Nikiforchin, Ekaterina Baron, Carol Nieroda, Vadim Gushchin, Teresa Diaz-Montes

Summary: This study evaluated the outcomes of ovarian carcinosarcoma (OCS) patients after cytoreduction with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). The results showed promising survival and abdominal disease control with CRS/HIPEC in advanced stage OCS patients, but further research is needed to validate these findings.
Article Oncology

Educational Collaboration Between Russian-Born US Physicians and Russian Oncology Trainees in Evidence-Based Medicine: The Higher School of Oncology

Ekaterina Baron, Michelle Sittig, Maxim Kotov, Ilya Fomintsev, Vadim Gushchin

Summary: The Higher School of Oncology (HSO) program, which involves US-trained Russian expatriate physicians as mentors, has significantly improved EBM and PCS skills among oncology residents in Russia.

JCO GLOBAL ONCOLOGY (2021)

暂无数据